Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antiviral activity against equine infectious anemia virus (EIAV) in oxygenated condition after 10 min of illumination, using focal immunoassay
Assay data:1 Tested
Summary
Antiviral activity against equine infectious anemia virus (EIAV) in oxygenated condition after 0 min of illumination, using focal immunoassay
Antiviral activity against equine infectious anemia virus (EIAV) in hypoxic condition obtained by passing nitrogen gas, after 10 min of illumination using focal, immunoassay
Antiviral activity against equine infectious anemia virus (EIAV) in hypoxic condition obtained by passing nitrogen gas, after 0 min of illumination using focal, immunoassay
Antiviral activity against equine infectious anemia virus (EIAV) in hypoxic condition obtained by passing argon gas, after 10 min of illumination, using focal immunoassay
Antiviral activity against equine infectious anemia virus (EIAV) in hypoxic condition obtained by passing argon gas, after 0 min of illumination, using focal immunoassay
Antiviral activity against equine infectious anemia virus (EIAV) in deoxygenation condition effected by using beta-carotene at a concentration of 80 uM
Antiviral activity against equine infectious anemia virus (EIAV) in deoxygenation condition effected by using beta-carotene at a concentration of 64 uM
Antiviral activity against equine infectious anemia virus (EIAV) in deoxygenation condition effected by using beta-carotene at a concentration of 32 uM
Antiviral activity against equine infectious anemia virus (EIAV) in deoxygenation condition effected by using beta-carotene at a concentration of 0 uM
In vitro anti-retroviral activity against equine infectious anemia virus(EIAV); compound was active
Assay data:2 Active, 2 Tested
SummaryCompounds, Active
In vitro anti-retroviral activity against equine infectious anemia virus(EIAV); Inactive
Assay data:2 Tested
Virucidal activity against RNA-containing equine infectious anemia virus (EIAV) at a concentration of 10 ug/mL by using a focal immunoassay; Activity expressed as log FFU/mL
Assay data:13 Tested
SummaryPubMed Citation
Virucidal activity against RNA-containing equine infectious anemia virus (EIAV) at a concentration of 10 ug/mL by using a focal immunoassay in the dark; Activity expressed as log FFU/mL
Assay data:9 Tested
Virucidal activity against RNA-containing equine infectious anemia virus (EIAV) at a concentration of 1.0 ug/mL by using a focal immunoassay in the light; Activity expressed as log FFU/mL
Assay data:8 Tested
Virucidal activity against RNA-containing equine infectious anemia virus (EIAV) at a concentration of 0.1 ug/mL by using a focal immunoassay in the light; Activity expressed as log FFU/mL
Assay data:11 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on